Breakpoints cover image

#60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID

Breakpoints

00:00

The Flagstone Study of Bollocks Severe Flu

The study question here was does adding bollocks severe which is our cap dependent into into nuclear inhibitors so novel mechanism of action influence and medication do adding it to a nerve and endase inhibitor improve treatment outcomes. The median time to cessation of viral shedding was much faster, almost two days faster in the group that got combination therapy versus monotherapy within the NAI's but unfortunately no hard clinical outcomes here. But what they did see is that when you give the two drugs together, the virus goes away faster in a test tube than with either one alone.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app